Literature DB >> 16273632

Value of endoscopic methylene blue and Lugol's iodine double staining and detection of GST-Pi and telomerase in the early diagnosis of esophageal carcinoma.

Xuan Zhu1, Shuang-Hong Zhang, Kun-He Zhang, Bi-Ming Li, Jiang Chen.   

Abstract

AIM: To explore the expressions of GST-Pi and telomerase activity in esophageal carcinoma and premalignant lesions and to investigate the value of endoscopic methylene blue (MB) and Lugol's iodine double staining.
METHODS: Seventy-two patients with esophagopathy were sprayed endoscopically with MB and Lugol's iodine in proper order and the areas stained blue and brown, and the area between the blue and brown stains were obtained. Depending on the pattern of mucosal staining, biopsy specimen was obtained. GST-Pi and telomerase activity in specimens were examined by immunohistochemistry and PCR-based silver staining telomeric repeat amplification protocol, respectively.
RESULTS: After MB and Lugol's iodine staining, the area between both the colors was obtained in 64 of the 72 patients and the areas were stained blue and brown in all of the 72 patients. Association test of two simultaneous ordinal categorical data showed a correlation between the esophageal mucosal staining and the esophageal histology (P<0.005). The expression of GST-Pi and telomerase activity in esophageal carcinoma and premalignant lesions increased. The expression of GST-Pi and telomerase activity in dysplasia and carcinoma was significantly higher than that in normal epithelium (P<0.005). The expression in hyperplasia was slightly higher than that in normal epithelium. With the lesions progressing from low- to moderate- to high-grade dysplasia, the positive rate increased (P<0.025). Expression of GST-Pi was correlated with that of telomerase activity in dysplasia and carcinoma (phis = 0.4831, P<0.005; phis = 0.3031, P<0.025, respectively); but there was no correlation between them in normal epithelium and hyperplasia.
CONCLUSION: The expression of GST-Pi and telomerase may be an early event in the carcinogenesis of esophagus. They may play an induced and synergistic role with each other in the carcinogenesis of esophagus. Endoscopic MB and Lugol's iodine double staining and detection of GST-Pi and telomerase activity may contribute to the early diagnosis of esophageal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273632      PMCID: PMC4436623          DOI: 10.3748/wjg.v11.i39.6090

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Telomerase activation. One step on the road to cancer?

Authors:  C W Greider
Journal:  Trends Genet       Date:  1999-03       Impact factor: 11.639

2.  Control of telomere length by the human telomeric protein TRF1.

Authors:  B van Steensel; T de Lange
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.

Authors:  Chun Li; Yingrui Liang; Mingyao Wu; Liyan Xu; Weijia Cai
Journal:  Chin Med J (Engl)       Date:  2002-09       Impact factor: 2.628

4.  Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.

Authors:  K Koyanagi; S Ozawa; N Ando; M Mukai; Y Kitagawa; M Ueda; M Kitajima
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

5.  Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.

Authors:  N Abe; T Watanabe; M Nakashima; T Masaki; T Mori; M Sugiyama; Y Atomi
Journal:  Hepatogastroenterology       Date:  2001 May-Jun

6.  The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis.

Authors:  K Sato; A Kitahara; K Satoh; T Ishikawa; M Tatematsu; N Ito
Journal:  Gan       Date:  1984-03

7.  Expression of glutathione S-transferase-pi messenger RNA in human esophageal cancers.

Authors:  C Ishioka; R Kanamaru; H Shibata; Y Konishi; A Ishikawa; A Wakui; T Sato; T Nishihira
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

8.  The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.

Authors:  Yuka Fujita; Toshiaki Fujikane; Satoru Fujiuchi; Yutaka Nishigaki; Yasuhiro Yamazaki; Atsushi Nagase; Tetsuo Shimizu; Yoshinobu Ohsaki; Kenjiro Kikuchi
Journal:  Cancer       Date:  2003-09-01       Impact factor: 6.860

9.  Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China.

Authors:  S L Qiu; G R Yang
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

10.  Telomerase activity in breast cancer in Western India (Gujarat).

Authors:  N G Shah; T J Choksi; D D Patel; H H Vora; N Ghosh; T I Trivedi; K A Trivedi
Journal:  Int J Biol Markers       Date:  2002 Jan-Mar       Impact factor: 3.248

View more
  4 in total

1.  Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.

Authors:  Laszlo Herszenyi; Istvan Hritz; Istvan Pregun; Ferenc Sipos; Mark Juhasz; Bela Molnar; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.

Authors:  Sumana Mukherjee; Mark J Roth; Sanford M Dawsey; Wusheng Yan; Jaime Rodriguez-Canales; Heidi S Erickson; Nan Hu; Alisa M Goldstein; Philip R Taylor; Annely M Richardson; Michael A Tangrea; Rodrigo F Chuaqui; Michael R Emmert-Buck
Journal:  J Transl Med       Date:  2010-10-05       Impact factor: 5.531

3.  Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis.

Authors:  Selvaraj Aranganathan; Jayabal Panneer Selvam; Namasivayam Nalini
Journal:  Invest New Drugs       Date:  2008-07-22       Impact factor: 3.850

4.  A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma.

Authors:  Jiali Lv; Jialin Wang; Xiaotao Shen; Jia Liu; Deli Zhao; Mengke Wei; Xia Li; Bingbing Fan; Yawen Sun; Fuzhong Xue; Zheng-Jiang Zhu; Tao Zhang
Journal:  Clin Transl Med       Date:  2021-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.